Prof. Dr. med. Andreas Meisel

Prof. Dr. med. Andreas Meisel is a distinguished neurologist and clinical scientist serving as the director of the stroke research center in Berlin (CSB) and a leading consultant at Charité University Hospital. His career is defined by a dual focus on high-level neurocritical care and groundbreaking experimental research into the systemic effects of brain injury. As the head of the integrated myasthenia gravis center, he has become a foremost expert in neuromuscular disorders, specifically focusing on the management of myasthenic crises and the implementation of novel immunotherapies. His research program is internationally recognized for uncovering the mechanisms of stroke-induced immunodepression, a condition where the central nervous system injury triggers a systemic immune deficiency, leading to life-threatening infections like pneumonia. By bridging the gap between bench and bedside, Professor Meisel develops innovative diagnostic biomarkers and therapeutic strategies to prevent post-stroke complications and promote brain repair. His leadership within the Berlin Stroke Alliance and his extensive editorial contributions highlight his pivotal role in modern vascular neurology and neuroimmunology.